Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen–progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women-Reference-Cited by-同舟云学术

Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen–progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women

Published:1997-03 Issue:2 Volume:129 Page:249-259
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Tilly-Kiesi Marju,Kahri Juhani,Pyörälä Tapani,Puolakka Jukka,Luotola Hannu,Lappi Mikko,Lahdenperä Sanni,Taskinen Marja-Riitta

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference66 articles.

1. Stampfer MJ, Willett WC, Coldiz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044.

2. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace, RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from Lipid Research Clinics Program Follow up Study. Circulation 1987;75:1102.

3. Barrett-Connor E, Bush T. Estrogen and coronary heart disease in women. JAMA 1991;14:1861-1867.

4. Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993;88:(part 1):2163.

5. Moorjani S, Dupont A, Labrie F et al. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women. J Clin Endocrinol Metab 1991;73:373.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive Cycle;Cell Reports;2016-04

2. Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100;Gynecological Endocrinology;2011-08-31

3. Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women;Atherosclerosis;2009-07

4. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins;Metabolism;2008-08

5. Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice;Journal of Lipid Research;2006-07